Inspire Advisors’s Globus Medical GMED Stock Holding History

Inspire Advisors’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$638K	Buy	7,410 +1,143	+18%	+$103K	0.05%	303
2025 Q4	$547K	Buy	+6,267	New	+$476K	0.05%	301

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Inspire Advisors's GMED Position: Q1 2026 in Review

Inspire Advisors increased its Globus Medical (GMED) stake by 18% in Q1 2026, buying an estimated $103K and bringing the position to 7,410 shares worth $638K. The position accounts for 0.05% of the portfolio, ranked #303.

Inspire Advisors first reported a position in GMED in Q4 2025 and has held it in 2 quarters since. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

Inspire Advisors held 7,410 shares of Globus Medical worth $638K as of Q1 2026.
Inspire Advisors bought 1,143 Globus Medical shares in Q1 2026, an estimated $103K.
Globus Medical made up 0.05% of Inspire Advisors's portfolio in Q1 2026, its #303 holding.
Inspire Advisors first reported a position in Globus Medical in Q4 2025 and has held it in 2 quarters since.
602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Inspire Advisors's 13F filing for Q1 2026, filed 15 May 2026.